Vela et al v. Merck & Company Incorporated et al
Plaintiff: Vela, Allen Vela and Edna Barba
Defendant: Merck & Company Incorporated and MERCK SHARP AND DOHME CORP.
Case Number: AZ/2:22-CV-00420
Filed: March 18, 2022
Court: Judicial Panel on Multidistrict Litigation
Presiding Judge: Steven P Logan
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on May 12, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
May 12, 2022 Filing 11 CERTIFICATE OF SERVICE re: pldg. (10 in AZ/2:22-cv-00398, 10 in AZ/2:22-cv-00420, #23 in MDL No. 3036) Filed by Plaintiffs Adriana Merino, Allen Vela -- Associated Cases: MDL No. 3036 , AZ/2:22-cv-00398, AZ/2:22-cv-00420 (Downing, Andrew)
May 12, 2022 Filing 10 NOTICE OF APPEARANCE re: pldg.( #1 in MDL No. 3036) Filed by Andrew Downing on behalf of Plaintiffs Adriana Merino, Allen Vela Associated Cases: MDL No. 3036, AZ/2:22-cv-00398, AZ/2:22 -cv-00420 (Downing, Andrew)
April 21, 2022 Filing 9 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #10 in MDL No. 3036) ) -- Motion of: Defendants Merck & Co., Inc., and Merck Sharp & Dohme Corp. for Extensi on of Time to File Response -- GRANTED TO ALL PARTIES. Responses due on or before 5/20/2022. Reply, if any, due on or before 5/27/2022. Signed by Clerk of the Panel John W. Nichols on 4/21/2022. Associated Cases: MDL No. 3036, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv-00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (JN)
April 21, 2022 Filing 8 ERRATA - to (7 in AZ/2:20-cv-01425, 7 in AZ/2:22-cv-00398, 7 in AZ/2:22-cv-00420, 7 in CAC/2:22-cv-01739, 7 in CAC/8:22-cv-00422, 7 in CAC/8:22-cv-00431, 7 in CAS/3:21-cv-00120, 2 in CT/3:21-cv-00438, 7 in FLM/8:21-cv-01814, 7 in FLM/8:21-cv-02903, 7 in FLN/3:21-cv-01335, 7 in FLS/9:22-cv-80445, 7 in GAN/1:22-cv-01171, 7 in GAN/1:22-cv-01178, 7 in HI/1:22-cv-00144, 7 in ILC/4:21-cv-04154, 7 in ILN/1:22-cv-01643, 7 in ILN/1:22-cv-01696, 7 in ILN/1:22-cv-01717, 7 in INN/1:22-cv-00116, 7 in LAM/3:22-cv-00210, 7 in MA/3:22-cv-10006, #10 in MDL No. 3036, 7 in MIE/5:21-cv-12324, 7 in NCM/1:22-cv-00212, 7 in NCW/3:22-cv-00117, 7 in NCW/5:22-cv-00030, 7 in NJ/3:22-cv-00116, 7 in NV/3:21-cv-00166, 7 in RI/1:20-cv-00364, 7 in SC/2:21-cv-02211, 7 in TXE/6:21-cv-00506, 7 in TXN/4:22-cv-00241, 7 in WIW/3:20-cv-01048, 7 in WVS/2:22-cv-00160), (6 in AZ/2:20-cv-01425, 6 in AZ/2:22-cv-00398, 6 in AZ/2:22-cv-00420, 6 in CAC/2:22-cv-01739, 6 in CAC/8:22-cv-00422, 6 in CAC/8:22-cv-00431, 6 in CAS/3:21-cv-00120, 6 in FLM/8:21-cv-01814, 6 in FLM/8:21-cv-02903, 6 in FLN/3:21-cv-01335, 6 in FLS/9:22-cv-80445, 6 in GAN/1:22-cv-01171, 6 in GAN/1:22-cv-01178, 6 in HI/1:22-cv-00144, 6 in ILC/4:21-cv-04154, 6 in ILN/1:22-cv-01643, 6 in ILN/1:22-cv-01696, 6 in ILN/1:22-cv-01717, 6 in INN/1:22-cv-00116, 6 in LAM/3:22-cv-00210, 6 in MA/3:22-cv-10006, 9 in MDL No. 3036, 6 in MIE/5:21-cv-12324, 6 in NCM/1:22-cv-00212, 6 in NCW/3:22-cv-00117, 6 in NCW/5:22-cv-00030, 6 in NJ/3:22-cv-00116, 6 in NV/3:21-cv-00166, 6 in RI/1:20-cv-00364, 6 in SC/2:21-cv-02211, 6 in TXE/6:21-cv-00506, 6 in TXN/4:22-cv-00241, 6 in WIW/3:20-cv-01048, 6 in WVS/2:22-cv-00160), (4 in AZ/2:20-cv-01425, 4 in AZ/2:22-cv-00398, 4 in AZ/2:22-cv-00420, 4 in CAC/2:22-cv-01739, 4 in CAC/8:22-cv-00422, 4 in CAC/8:22-cv-00431, 4 in CAS/3:21-cv-00120, 4 in FLM/8:21-cv-01814, 4 in FLM/8:21-cv-02903, 4 in FLN/3:21-cv-01335, 4 in FLS/9:22-cv-80445, 4 in GAN/1:22-cv-01171, 4 in GAN/1:22-cv-01178, 4 in HI/1:22-cv-00144, 4 in ILC/4:21-cv-04154, 4 in ILN/1:22-cv-01643, 4 in ILN/1:22-cv-01696, 4 in ILN/1:22-cv-01717, 4 in INN/1:22-cv-00116, 4 in LAM/3:22-cv-00210, 4 in MA/3:22-cv-10006, #7 in MDL No. 3036, 4 in MIE/5:21-cv-12324, 4 in NCM/1:22-cv-00212, 4 in NCW/3:22-cv-00117, 4 in NCW/5:22-cv-00030, 4 in NJ/3:22-cv-00116, 4 in NV/3:21-cv-00166, 4 in RI/1:20-cv-00364, 4 in SC/2:21-cv-02211, 4 in TXE/6:21-cv-00506, 4 in TXN/4:22-cv-00241, 4 in WIW/3:20-cv-01048, 4 in WVS/2:22-cv-00160), (5 in AZ/2:20-cv-01425, 5 in AZ/2:22-cv-00398, 5 in AZ/2:22-cv-00420, 5 in CAC/2:22-cv-01739, 5 in CAC/8:22-cv-00422, 5 in CAC/8:22-cv-00431, 5 in CAS/3:21-cv-00120, 5 in FLM/8:21-cv-01814, 5 in FLM/8:21-cv-02903, 5 in FLN/3:21-cv-01335, 5 in FLS/9:22-cv-80445, 5 in GAN/1:22-cv-01171, 5 in GAN/1:22-cv-01178, 5 in HI/1:22-cv-00144, 5 in ILC/4:21-cv-04154, 5 in ILN/1:22-cv-01643, 5 in ILN/1:22-cv-01696, 5 in ILN/1:22-cv-01717, 5 in INN/1:22-cv-00116, 5 in LAM/3:22-cv-00210, 5 in MA/3:22-cv-10006, #8 in MDL No. 3036, 5 in MIE/5:21-cv-12324, 5 in NCM/1:22-cv-00212, 5 in NCW/3:22-cv-00117, 5 in NCW/5:22-cv-00030, 5 in NJ/3:22-cv-00116, 5 in NV/3:21-cv-00166, 5 in RI/1:20-cv-00364, 5 in SC/2:21-cv-02211, 5 in TXE/6:21-cv-00506, 5 in TXN/4:22-cv-00241, 5 in WIW/3:20-cv-01048, 5 in WVS/2:22-cv-00160) - Filed by Defendants Merck & Co., Inc., Merck Sharp & Dohme Corp. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED DUPLICATE PARTY NAMES Modified on 4/22/2022 (CMD).
April 21, 2022 Filing 7 MOTION FOR EXTENSION OF TIME TO FILE RESPONSE re: pldg. ( 3 in MDL No. 3036), ( #1 in MDL No. 3036), ( #4 in MDL No. 3036) Filed by Allyson Julien on behalf of Defendants Merck Sharp & Dohme Corp., #et al.Merck & Co., Inc. #[Suppress List] (Attachments: #1 Declaration, #2 Schedule of Actions, #3 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED DUPLICATE PARTY NAMES Modified on 4/21/2022 (CMD).
April 21, 2022 Filing 6 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3036) -- Identifying Corporate Parent MERCK & CO., INC., for MERCK SHARP & DOHME CORP.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED MDL LINKS & DUPLICATE PARTY NAME Modified on 4/21/2022 (CMD).
April 21, 2022 Filing 5 CORPORATE DISCLOSURE STATEMENT re: pldg. ( #1 in MDL No. 3036) -- Identifying Corporate Parent No Parent Corporation for Merck & Co, Inc.. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED MDL LINKS & DUPLICATE PARTY NAME Modified on 4/21/2022 (CMD).
April 21, 2022 Filing 4 NOTICE OF APPEARANCE re: pldg.( 3 in MDL No. 3036), ( #1 in MDL No. 3036), ( #4 in MDL No. 3036) Filed by Allyson Julien on behalf of Defendants Merck Sharp & Dohme Corp., Merck & Co., Inc. (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3036 et al. (Julien, Allyson) DELETED DUPLICATE PARTY NAMES Modified on 4/21/2022 (CMD).
April 15, 2022 Filing 3 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #1 in MDL No. 3036) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 4/29/2022. Corporate Disclosure Statements due on or before 4/29/2022. Responses due on or before 5/6/2022. Reply, if any, due on or before 5/13/2022. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Signed by Clerk of the Panel John W. Nichols on 4/15/2022. Associated Cases: MDL No. 3036, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv-00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (CMD)
April 15, 2022 Filing 2 MDL Number 3036 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #1 in Pending No. 76) Associated Cases: Pending No. 76, AZ/2:20-cv-01425, AZ/2:22-cv-00398, AZ/2:22-cv- 00420, CAC/2:22-cv-01739, CAC/8:22-cv-00422, CAC/8:22-cv-00431, CAS/3:21-cv-00120, FLM/8:21-cv-01814, FLM/8:21-cv-02903, FLN/3:21-cv-01335, FLS/9:22-cv-80445, GAN/1:22-cv-01171, GAN/1:22-cv-01178, HI/1:22-cv-00144, ILC/4:21-cv-04154, ILN/1:22-cv-01643, ILN/1:22-cv-01696, ILN/1:22-cv-01717, INN/1:22-cv-00116, LAM/3:22-cv-00210, MA/3:22-cv-10006, MIE/5:21-cv-12324, NCM/1:22-cv-00212, NCW/3:22-cv-00117, NCW/5:22-cv-00030, NJ/3:22-cv-00116, NV/3:21-cv-00166, RI/1:20-cv-00364, SC/2:21-cv-02211, TXE/6:21-cv-00506, TXN/4:22-cv-00241, WIW/3:20-cv-01048, WVS/2:22-cv-00160 (CMD)
April 13, 2022 Filing 1 SEE CORRECTED PLDG. 4CERTIFICATE OF SERVICE re: pldg. ( #1 in Pending No. 76) Associated Cases: Pending No. 76 et al. (Esfandiari, Bijan) Modified on 4/15/2022 (CMD).

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Judicial Panel on Multidistrict Litigation's Electronic Court Filings (ECF) System

Search for this case: Vela et al v. Merck & Company Incorporated et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Vela
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Allen Vela
Represented By: Andrew Downing
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Edna Barba
Represented By: Andrew Downing
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Merck & Company Incorporated
Represented By: Allyson Julien
Represented By: Merck & Co., Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MERCK SHARP AND DOHME CORP.
Represented By: Allyson Julien
Represented By: Merck Sharp & Dohme Corp.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?